Odyssey Therapeutics, Inc. (ODTX) News
Follow Odyssey Therapeutics, Inc. (ODTX) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 6 public stories across 5 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
ODTX - Odyssey Therapeutics to Participate in Stifel 2026 Virtual Immunology and Inflammation Forum
ODTX - Odyssey Therapeutics to Participate in Stifel 2026 Virtual Immunology and Inflammation Forum
NEWS | Sep 16, 2026, 12:00 PM UTC
M
Odyssey Therapeutics reports positive OD-001 Phase 2a results
Odyssey Therapeutics said OD-001 met Phase 2a success criteria and reported $433 million in cash, expected to fund operations into H2 2028.
REGULATION | Sep 09, 2026, 10:04 AM UTC
L
Odyssey Therapeutics initiated at Buy by HC Wainwright
HC Wainwright & Co. initiated Odyssey Therapeutics at Buy.
EQUITY | Aug 27, 2026, 12:34 PM UTC
L
Odyssey Therapeutics to Participate in Upcoming Investor Conferences
Odyssey Therapeutics to Participate in Upcoming Investor Conferences
EQUITY | Aug 26, 2026, 12:08 PM UTC
L
ODTX - Odyssey Therapeutics to Participate in Upcoming Investor Conferences
ODTX - Odyssey Therapeutics to Participate in Upcoming Investor Conferences
EQUITY | Aug 26, 2026, 12:00 PM UTC
L
ODTX - Odyssey Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
ODTX - Odyssey Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
EARNINGS | Aug 04, 2026, 11:01 AM UTC